|
Oct 9
|
Biofrontera Inc (BFRI) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Oct 7
|
FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment
|
|
Jul 12
|
When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable?
|
|
Jun 24
|
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
|
|
May 15
|
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
|
|
May 6
|
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
|
|
May 3
|
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
|
|
Mar 26
|
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
|
|
Mar 24
|
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
|
|
Mar 19
|
Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
|
|
Mar 19
|
Q4 2023 Biofrontera Inc Earnings Call
|
|
Mar 16
|
CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
|
|
Mar 15
|
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
|
|
Mar 8
|
Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
|
|
Jan 31
|
Biofrontera Inc. (NASDAQ:BFRI): Is Breakeven Near?
|
|
Jan 11
|
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
|
|
Nov 3
|
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10
|
|
Aug 28
|
Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)
|
|
Jul 3
|
Breakeven On The Horizon For Biofrontera Inc. (NASDAQ:BFRI)
|
|
Jul 3
|
Biofrontera Inc. Announces 1-for-20 Reverse Stock Split
|